Roanoke Asset Management Corp NY Reduces Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Roanoke Asset Management Corp NY trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH) by 2.6% in the 4th quarter, HoldingsChannel reports. The firm owned 94,740 shares of the company’s stock after selling 2,500 shares during the quarter. Roanoke Asset Management Corp NY’s holdings in Option Care Health were worth $2,198,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of OPCH. Versor Investments LP acquired a new stake in shares of Option Care Health in the fourth quarter worth $452,000. Illinois Municipal Retirement Fund grew its position in Option Care Health by 114.2% during the 4th quarter. Illinois Municipal Retirement Fund now owns 34,460 shares of the company’s stock worth $799,000 after purchasing an additional 18,370 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in shares of Option Care Health during the 4th quarter valued at about $327,000. Olympiad Research LP acquired a new position in shares of Option Care Health in the 4th quarter valued at about $360,000. Finally, New York State Common Retirement Fund boosted its stake in shares of Option Care Health by 14.6% in the fourth quarter. New York State Common Retirement Fund now owns 246,034 shares of the company’s stock worth $5,708,000 after buying an additional 31,400 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $33.50 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market capitalization of $5.70 billion, a PE ratio of 28.15, a P/E/G ratio of 2.30 and a beta of 1.35. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.17. The company has a fifty day moving average of $28.70 and a two-hundred day moving average of $28.09.

Analyst Ratings Changes

Several brokerages recently weighed in on OPCH. UBS Group assumed coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. Barrington Research lifted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday. JPMorgan Chase & Co. increased their price target on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $32.88.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.